Article thumbnail

Résistances thérapeutiques dans les mouvements anormaux [Resistance to treatment in movement disorders].

By F.J. Vingerhoets and P.R. Burkhard


Therapeutic strategies for essential tremor (ET) and Parkinson's disease (PD) can be divided into two successive steps, one based on oral medications and the other, more invasive, using pumps or functional neurosurgery. When ET becomes refractory to propranolol, primidone and other, second-choice compounds, deep brain stimulation of the VIM nucleus of the thalamus can be considered. When PD becomes resistant to dopamine replacement therapy using various combinations of dopaminergic agents, then three options can be discussed: first, a subcutaneous apomorphine mini-pump, second, a jejunal levodopa-delivery system by means of percutaneous gastrostomy, and third, bilateral deep brain stimulation of the subthalamic nucleus. The above interventions are successful in about 80% of cases

Topics: Antiparkinson Agents/administration & dosage; Antiparkinson Agents/therapeutic use; Apomorphine/administration & dosage; Apomorphine/therapeutic use; Deep Brain Stimulation/methods; Deep Brain Stimulation/psychology; Drug Resistance/physiology; Essential Tremor/diagnosis; Essential Tremor/etiology; Humans; Levodopa/administration & dosage; Levodopa/therapeutic use; Movement Disorders/diagnosis; Movement Disorders/etiology; Neurosurgery/methods; Parkinson Disease/diagnosis; Parkinson Disease/etiology; Treatment Failure
Year: 2012
OAI identifier:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.